XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.22.1

Business Segments (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2022
Business Segments |
Schedule of information regarding reportable segments | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months |  | Nine Months | ​
For the Periods Ended March 31 |  | 2022 |  | 2021 |  | 2022 |  | 2021 | ​
Net sales |  |  |  |  |  |  |  |  |  |  |  |  |
Animal Health | ​ | $ | 148,589 | ​ | $ | 134,380 | ​ | $ | 440,520 | ​ | $ | 398,987 | ​
Mineral Nutrition | ​ |  | 69,033 | ​ |  | 58,153 | ​ |  | 190,120 | ​ |  | 163,750 | ​
Performance Products | ​ |  | 21,997 | ​ |  | 19,196 | ​ |  | 56,356 | ​ |  | 50,335 | ​
Total segments | ​ | $ | 239,619 | ​ | $ | 211,729 | ​ | $ | 686,996 | ​ | $ | 613,072 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 6,935 | ​ | $ | 6,457 | ​ | $ | 19,872 | ​ | $ | 19,476 | ​
Mineral Nutrition | ​ |  | 661 | ​ |  | 646 | ​ |  | 1,960 | ​ |  | 2,042 | ​
Performance Products | ​ |  | 436 | ​ |  | 416 | ​ |  | 1,292 | ​ |  | 1,284 | ​
Total segments | ​ | $ | 8,032 | ​ | $ | 7,519 | ​ | $ | 23,124 | ​ | $ | 22,802 | ​
Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 29,232 | ​ | $ | 30,962 | ​ | $ | 90,565 | ​ | $ | 94,412 | ​
Mineral Nutrition | ​ |  | 7,303 | ​ |  | 5,232 | ​ |  | 17,361 | ​ |  | 12,464 | ​
Performance Products | ​ |  | 2,865 | ​ |  | 2,929 | ​ |  | 6,327 | ​ |  | 7,167 | ​
Total segments | ​ | $ | 39,400 | ​ | $ | 39,123 | ​ | $ | 114,253 | ​ | $ | 114,043 | ​
Reconciliation of income before income taxes to Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income before income taxes | ​ | $ | 26,833 | ​ | $ | 17,782 | ​ | $ | 59,958 | ​ | $ | 50,343 | ​
Interest expense, net | ​ |  | 2,925 | ​ |  | 2,933 | ​ |  | 8,767 | ​ |  | 8,957 | ​
Depreciation and amortization – Total segments | ​ |  | 8,032 | ​ |  | 7,519 | ​ |  | 23,124 | ​ |  | 22,802 | ​
Depreciation and amortization – Corporate | ​ |  | 413 | ​ |  | 399 | ​ |  | 1,176 | ​ |  | 1,240 | ​
Corporate costs | ​ | ​ | 11,404 | ​ | ​ | 11,073 | ​ | ​ | 34,699 | ​ | ​ | 33,162 | ​
Gain on sale of investment | ​ |  | — | ​ |  | — | ​ |  | (1,203) | ​ |  | — | ​
Acquisition-related costs of goods sold | ​ |  | 78 | ​ |  | — | ​ |  | 78 | ​ |  | — | ​
Acquisition-related transaction costs | ​ |  | 279 | ​ |  | — | ​ |  | 279 | ​ |  | — | ​
Stock-based compensation | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | 1,129 | ​
Foreign currency (gains) , net | ​ |  | (10,564) | ​ |  | (583) | ​ |  | (12,625) | ​ |  | (3,590) | ​
Adjusted EBITDA – Total segments | ​ | $ | 39,400 | ​ | $ | 39,123 | ​ | $ | 114,253 | ​ | $ | 114,043 | ​
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, |  | June 30,
As of |  | 2022 |  | 2021
Identifiable assets |  | ​ |  |  | ​ |
Animal Health | ​ | $ | 647,490 | ​ | $ | 595,315
Mineral Nutrition | ​ |  | 82,378 | ​ |  | 67,338
Performance Products | ​ |  | 38,395 | ​ |  | 36,847
Total segments | ​ |  | 768,263 | ​ |  | 699,500
Corporate | ​ |  | 147,918 | ​ |  | 141,825
Total | ​ | $ | 916,181 | ​ | $ | 841,325

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration